S, Y., MA, P., K, S., CB, G., P, H., JJV, M., . . . Committees, C. I. a. (2003). Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet, 362(9386), 777. https://doi.org/10.1016/s0140-6736(03)14285-7
Chicago Style (17th ed.) CitationS, Yusuf, et al. "Effects of Candesartan in Patients with Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction: The CHARM-Preserved Trial." Lancet 362, no. 9386 (2003): 777. https://doi.org/10.1016/s0140-6736(03)14285-7.
MLA (9th ed.) CitationS, Yusuf, et al. "Effects of Candesartan in Patients with Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction: The CHARM-Preserved Trial." Lancet, vol. 362, no. 9386, 2003, p. 777, https://doi.org/10.1016/s0140-6736(03)14285-7.